Endorsement of registration identifies practitioners with additional qualifications and specific expertise. The endorsement available for podiatry is scheduled medicines.
The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines came into effect on 1 August 2018.
The revised registration standard and guidelines apply to podiatrists and podiatric surgeons applying for endorsement for scheduled medicines after 1 August 2018.
FAQ are available to help practitioners understand the new registration standard and guidelines.
Templates and a Prescribing Self Assessment Tool are also available to support practitioners using Pathway B of the registration standard to endorsement.
Watch our two videos about Pathway B to endorsement for scheduled medicines and discover what you and your mentor need to do during your period of supervised practice.
Video: Endorsement for scheduled medicines – key steps for Pathway B
Video: Key information about the mentor role under Pathway B
The Podiatry Board of Australia recognises that the ongoing lockdowns and variable restrictions across the country may be having an impact on practitioners undertaking their period of supervised practice under Pathway B of the Board’s Registration standard: Endorsement for scheduled medicines
We encourage practitioners in Pathway B to continue with your learning, attend observational clinical placements where they are available in line with the COVID-19 guidance in your state or territory and it is safe for you to do so. We also encourage you to continue having discussions with your mentor, develop your clinical studies and work on your portfolio of evidence as much as you can. This may include submitting your three clinical studies for initial assessment depending on where you are in the pathway.
For those practitioners who are having difficulties completing their period of supervised practice within the required timeframe due to the impacts of COVID-19, we encourage you to apply for an extension under the Board’s Policy: Extension of time to complete period of supervised practice under Pathway B.
Applications for an extension will be assessed and responded to as quickly as possible.
The policy is published in the table below. The application form for an extension is published on the Forms page.
There are specific forms for practitioners applying to have their registration endorsed for scheduled medicines.
There are also forms to complete if you need to change your mentor or if you want to apply for an extension of time to complete your period of supervised practice under Pathway B.
The forms are available on our Forms page.
One of the requirements under Pathway B of the Board’s Registration standard: Endorsement for scheduled medicines (ESM registration standard) is the successful completion of 15 online case studies approved by the Board.
The Board has approved the following online case studies for the purpose of Pathway B of the ESM registration standard:
An endorsement for scheduled medicines may be subject to a condition. For more information please visit the Endorsement for schedule medicines subject to a condition page.